| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 10.02.
| GlaxoSmithKline PLC: Transaction in Own Shares | | 5 | InvestEgate |
| 10.02.
| GlaxoSmithKline PLC: Director/PDMR Shareholding | | - | InvestEgate |
| 10.02.
| GlaxoSmithKline PLC: Director/PDMR Shareholding | | - | InvestEgate |
| 10.02.
| GlaxoSmithKline PLC: Director/PDMR Shareholding | | 1 | InvestEgate |
| 09.02.
| GlaxoSmithKline PLC: Transaction in Own Shares | | 5 | InvestEgate |
| 09.02.
| How the Wheels Came off GlaxoSmithKline's Bus | | 4 | Motley Fool |
| 09.02.
| Prestige Brands Holdings, Inc. Reports Fiscal 2012 Third Quarter Sales Increase of 17.3%; Operating Income Up 81.4%; Acquisition of 15 OTC Brands from GSK Completed | | 40 | Business Wire |
| Prestige Brands Holdings, Inc. (NYSE: PBH) today announced results for
the fiscal 2012 third quarter ended December 31, 2011, including net
revenues of $106.3 million...
Mehr lesen zu:
Prestige Brands Holdings, Inc. Reports Fiscal 2012 Third Quarter Sales Increase of 17.3%; Operating Income Up 81.4%; Acquisition of 15 OTC Brands from GSK Completed | |
| 09.02.
| GSK launches Medivir cold sore OTC product in Europe | | 3 | Pharma Bus Review |
| 09.02.
| GlaxoSmithKline gets out of red in Q4 with US$1.98 bil. profit | | - | China Post |
| 09.02.
| GlaxoSmithKline: A Good Mix Of Income And Opportunity | | 4 | Seeking Alpha |
| 08.02.
| GlaxoSmithKline PLC: Transaction in Own Shares | | 3 | InvestEgate |
| 08.02.
| Glaxo Misses Estimates by a Mile | | 3 | Zacks |
| 08.02.
| Broker snap: Credit Suisse cautious about 2012 at Glaxo | | 5 | ShareCast |
| 08.02.
| GlaxoSmithKline PLC: Director/PDMR Shareholding | | 2 | InvestEgate |
| 08.02.
| Glaxo Smith Kline schmelzt dahin | | 64 | Bernecker Börsenbriefe |
| Die Erlöse bei dem Pharmakonzern schrumpfen weitaus mehr als im Vorfeld erwartet. Für das vierte Quartal 2011 wies das Unternehmen einen Umsatzrückgang um 2 % auf 6,98 Mrd. Pfund - 8,31 Mrd. Euro -...
Mehr lesen zu:
Glaxo Smith Kline schmelzt dahin | |
| 08.02.
| Medivir: Medivir's Partner GSK Initiates OTC Launch of Xerclear® in Europe under Trade Names Zoviduo and Zovirax Duo | | 44 | Business Wire |
| Regulatory News:
Medivir AB (STO:MVIRB), the research-based specialty pharmaceutical
company focused on infectious diseases, announces that its unique cold...
Mehr lesen zu:
Medivir: Medivir's Partner GSK Initiates OTC Launch of Xerclear® in Europe under Trade Names Zoviduo and Zovirax Duo | |
| 08.02.
| Medivir's Partner GSK Initiates OTC Launch of Xerclear® in Europe Under Trade Names Zoviduo and Zovirax Duo | | 34 | PR Newswire |
| HUDDINGE, Sweden, February 8, 2012 /PRNewswire/ --
Medivir AB (OMX:MVIR), the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product...
Mehr lesen zu:
Medivir's Partner GSK Initiates OTC Launch of Xerclear® in Europe Under Trade Names Zoviduo and Zovirax Duo | |
| 08.02.
| Healthy GlaxoSmithKline raises its dividend and plans to create jobs | | 10 | This Is Money |
| 08.02.
| GSK talks up new drugs in pipeline | | 2 | The Scotsman |
| 07.02.
| Drugmaker GSK sweeps cash daily from euro zone | | 3 | Reuters.com |
